The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis
Abstract
Genetic susceptibility to type 1 autoimmune hepatitis is indicated by a preponderance of female subjects and strong associations with human leukocyte antigens (HLA) DRB1*0301 and DRB1*0401. The gene encoding cytotoxic T-lymphocyte antigen-4 (CTLA-4) on chromosome 2q33 may also influence autoimmunity. To determine the frequency and significance of the exon 1 adenine (A)-guanine (G) base-exchange polymorphism for CTLA-4 in patients with type 1 autoimmune hepatitis, 155 northern European Caucasoid patients and 102 ethnically-matched control subjects were tested by polymerase chain reaction. The genotype distribution was significantly different in patients compared to controls (AA = 50/155 patients vs. 51/102 controls; AG = 84/155 patients vs. 38/102 controls; GG = 21/155 patients vs. 13/102 controls, χ 2 = 8.94, P = .011). This difference was caused by a significant over-representation of the G allele in patients compared to controls (105/155 patients vs. 51/102 controls, χ 2 = 8.34, P = .004, odds ratio = 2.12). The GG genotype was associated with a significantly higher mean serum aspartate transaminase level (P = .03), greater frequency of antibodies to thyroid microsomal antigens (P = .004) and was found more commonly in patients with HLA DRB1*0301 (P = .02). Treatment outcomes, however, were not affected by the genotype. The CTLA-4 G allele is more common in patients with type 1 autoimmune hepatitis and may represent a second susceptibility allele. Furthermore, there may be synergy between the HLA-DRB1*0301 and the GG genotype in terms of disease risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 1×
“Developed cirrhosis 8/30 (27) 12/40 (30) 5/11 (45) 20/70 (29)”
Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., Bernal, W., Czaja, A. J., & Donaldson, P. T. (1999) · Hepatology · doi:10.1002/hep.510300412 · Cited by 180 · cited 2×
“body 3/49 (6) 13/82 (16) 3 (14) 16/131 (12)”
Self-citation
Cited by
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“Susceptibility for AIH has been associated with genetic polymorphisms encoding cytotoxic T lymphocyte antigen-4 (CTLA-4),(33) tumor necrosis factor-alpha (TNF-α),(34,35) Fas (cluster of differentiation 95 [CD95] or apoptosis antigen-1),(36,37) vitamin D receptor,(38,39) signal transducer and activator of transcription…”
BackgroundSelf-citationKrawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 753
Autoimmune hepatitis – Update 2015
Manns, M. P., Lohse, A. W., & Vergani, D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.005 · Cited by 371
Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
de Boer, Y. S., van Gerven, N. M. F., Zwiers, A., Verwer, B. J., van Hoek, B., van Erpecum, K. J., Beuers, U., van Buuren, H. R., Drenth, J. P. H., den Ouden, J. W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.022 · Cited by 304
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Self-citationHeneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases
Sîrbe, C., Rednic, S., Grama, A., & Pop, T. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179784 · Cited by 269
Vogel, A., Strassburg, C. P., & Manns, M. P. (2002) · Hepatology · doi:10.1053/jhep.2002.30084 · Cited by 259
Drug-induced autoimmune-like hepatitis
Czaja, A. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1611-4 · Cited by 235
Self-citationThe Genetics of Autoimmune Thyroid Disease
Vaidya, B., Kendall-Taylor, P., & Pearce, S. H. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020492 · Cited by 164
Agarwal, K., Czaja, A. J., & Donaldson, P. T. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00794.x · Cited by 86
Self-citation“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
Genome‐wide meta‐analysis identifies susceptibility loci for autoimmune hepatitis type 1
Li, Y., Sun, Y., Liu, Y., Wang, B., Li, J., Wang, H., Zhang, H., Wang, X., Han, X., Lin, Q., et al. (2022) · Hepatology · doi:10.1002/hep.32417 · Cited by 37
Metadata
- Authors
- Agarwal, K., Czaja, A. J., Jones, D. E., & Donaldson, P. T.
- Venue
- Hepatology
- Published
- 2000-01
- Volume
- 31
- Issue
- 1
- Pages
- 49-53
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2006493179
- Cited by
- 244
- References
- 2
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.